Modulation of expression and cellular distribution of p21 by macrophage migration inhibitory factor.
BACKGROUND
The pleiotropic protein MIF, (macrophage migration inhibitory factor), has been demonstrated to modulate several key proteins governing cell cycle control and is considered to contribute to cell growth and differentiation. In this study we investigated the effect of MIF on the expression and cellular distribution of the CDK inhibitor p21.


METHODS
The effect of endogenous MIF on p21 expression and distribution was examined by comparing murine dermal fibroblasts derived from wt and MIF -/- mice. The effect of MIF on cell growth and apoptotic rates was compared using 3H-Thymidine incorporation assays and annexin V/PI assays respectively. Total p21 protein levels were compared using flow cytometry and western blotting. p21 mRNA was assessed by RT-PCR. Intracellular p21 staining was performed to assess cellular distribution of total protein. To further confirm observations siRNA was used to knockdown MIF protein in wt cells. Cell cycle analysis was performed using PI incorporation assays.


RESULTS
MIF-/- murine dermal fibroblasts exhibited reduced proliferative responses and were more susceptible to apoptosis. This was associated with reduced p21 expression and nuclear distribution. Treatment with recombinant MIF protein was demonstrated to reduce both basal and induced apoptosis and increase nuclear p21 expression. Reduced nuclear p21 expression was also observed in MIF siRNA treated wt cells.


CONCLUSIONS
The results demonstrate that in the absence of MIF p21 expression and nuclear distribution is reduced which is associated with a reduction in cell growth and increased apoptosis. MIF may therefore play a role in maintaining homeostatic control of p21.
Taranto
Elliott
E
Centre for Inflammatory Diseases, Monash University Department of Medicine, Monash Medical Centre, Clayton, Melbourne, Australia. michelle.leech@med.monash.edu.au.
Xue
Jin R
JR
Morand
Eric F
EF
Leech
Michelle
M
J Immunol. 2003 Mar 15;170(6):3337-47
12626594
Pathol Biol (Paris). 2000 Apr;48(3):190-202
10858953
Mol Cancer Ther. 2007 Jul;6(7):1993-2002
17620429
Cancer Res. 1995 Nov 15;55(22):5187-90
7585571
Circ Res. 2003 Aug 22;93(4):321-9
12881477
J Biol Chem. 2002 Aug 16;277(33):29792-802
12058028
Oncogene. 1999 Feb 4;18(5):1239-44
10022130
Cell Signal. 2006 Feb;18(2):236-43
15979845
Genes Dev. 1997 Apr 1;11(7):847-62
9106657
Oncogene. 2000 Nov 9;19(47):5338-47
11103935
Biochem Biophys Res Commun. 2000 Mar 5;269(1):179-90
10694497
J Biol Chem. 2005 Jun 17;280(24):23066-72
15840582
Mol Med. 2000 Sep;6(9):736-49
11071269
Arch Biochem Biophys. 2005 Nov 15;443(1-2):113-9
16248979
Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):345-50
11756671
Cell Signal. 2006 May;18(5):688-703
16122907
Arthritis Rheum. 2003 Jul;48(7):1881-9
12847682
Nat Rev Drug Discov. 2006 May;5(5):399-410
16628200
Ann N Y Acad Sci. 2003 May;995:171-82
12814949
J Biol Chem. 2003 Sep 26;278(39):37256-64
12867429
FASEB J. 2007 May;21(7):1393-402
17264161
Mol Cell Biol. 2000 Aug;20(16):6147-58
10913196
EMBO J. 2007 Feb 21;26(4):987-97
17290223
J Biol Chem. 2003 Jan 3;278(1):76-81
12297513
EMBO J. 1999 Mar 1;18(5):1223-34
10064589
J Rheumatol. 2004 Jun;31(6):1038-43
15170913
FEBS Lett. 2000 Apr 21;472(1):50-2
10781803
Mol Med. 1999 Mar;5(3):181-91
10404515
Cell Signal. 2004 Feb;16(2):263-9
14636896
J Immunol. 2000 Apr 15;164(8):4032-6
10754295
Cancer Res. 1994 Mar 1;54(5):1169-74
8118801
Nat Rev Immunol. 2003 Oct;3(10):791-800
14502271
Glia. 2006 Jan 15;53(2):147-57
16206162
J Biol Chem. 2002 Mar 8;277(10):8517-23
11751903
J Exp Med. 1999 Nov 15;190(10):1375-82
10562313
Cancer Res. 2001 Aug 15;61(16):6234-8
11507077
Wien Med Wochenschr. 2006 Jan;156(1-2):11-8
16465610
Cell Signal. 2004 Jan;16(1):13-9
14607271
J Exp Med. 1999 Jan 18;189(2):341-6
9892616
Oncogene. 1999 Aug 19;18(33):4689-98
10467416
Am J Pathol. 2006 May;168(5):1531-41
16651620
Arthritis Rheum. 2003 Jan;48(1):103-9
12528110
Semin Thromb Hemost. 1999;25(6):563-8
10632479
Int J Mol Med. 2002 Oct;10(4):463-7
12239594
Oncogene. 1998 Aug 27;17(8):931-9
9747872
Clin Cancer Res. 2005 Feb 1;11(3):1050-8
15709171
Semin Cancer Biol. 2000 Oct;10(5):359-66
11100884
EMBO J. 1999 Mar 15;18(6):1571-83
10075928